| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
2e-09 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0004 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |